Special Lecture on Korea-Developed Pharmaceutical and Bio AI Model for Researchers

The Korea Pharmaceutical and Bio-Pharma Manufacturers Association’s AI Drug Discovery Institute announced on August 31 that it will host a special seminar titled "Catching Up with AI Drug Development: K-FOLD Introductory Lecture" at the association’s office in Seocho-gu, Seoul, on September 1.


This seminar is designed to help participants understand the background and operational principles of the next-generation bio artificial intelligence (AI) model K-FOLD, which was recently unveiled by KAIST, and directly experience ways to apply it to actual drug discovery research.


KPBMA AI New Drug Research Center to Host Special Seminar on "KFold" View original image

K-FOLD is a next-generation bio AI model developed by "Team KAIST" under the leadership of Professor Kim Wooyeon from the Department of Chemistry at KAIST, who previously served as the Director of the AI Drug Development Support Center. In addition to predicting the three-dimensional structures of proteins, K-FOLD can also predict various molecular interactions and binding structures among proteins, drug candidates, DNA, and RNA.


At the seminar, Hwang Sangyeon, Head of Advanced Research at HITS, will explain the specialized foundation model project and the objectives of K-FOLD training, the background of K-FOLD’s development and its model principles, and its prediction performance and advancement directions. Following this, there will be a hands-on practice session using K-FOLD through HyperLab.



Noh Yeonhong, President of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association, stated, “Technologies like K-FOLD not only lower the barriers for researchers to utilize AI, thereby accelerating and improving the efficiency of drug candidate exploration, but are also expected to serve as a catalyst to elevate the research and development competitiveness of our pharmaceutical and biotech industry in the long term.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing